Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
JAMA Oncology|August 30, 2019
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical TrialCarlos Fernández-Martos, Carles Pericay, Ferran Losa, et al.
Journal of the National Cancer Institute|July 5, 2023
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402David Pesántez, Sanne Ten Hoorn, Isidro Machado, et al.
Molecular Cancer Therapeutics|June 20, 2017
Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal CancerCristina Santos, Daniel Azuara, Rocio Garcia-Carbonero, et al.
Molecular Oncology|April 25, 2023
Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre networkNúria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B StudyJoana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall, et al.
Lancet (London, England)|August 3, 2024
Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 studyAlwin Krämer, Tilmann Bochtler, Chantal Pauli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based TreatmentSara Cabrero-de Las Heras, Xavier Hernández-Yagüe, Andrea González, et al.
Pageof 3